Align Technology | ALGN - Capitaux D'Emprunt

Prix De L'Action
156.18
Variation Quotidienne
-2.60 -1.64%
Mensuellement
-18.51%
Annuel
-14.46%
Q2 Prévisions
154.09




Capitaux D'Emprunt Changement Date
3M USD 10.91B 26M 2026-03
Align Technology USD 0 0 2024-12
Becton, Dickinson and Co. USD 14.71B 2.21B 2026-03
Bruker USD 1.66B 189.6M 2026-03
Cardinal Health USD 8.25B 102M 2026-03
Charles River Laboratories USD 2.66B 526.77M 2026-03
Cooper Companies USD 1.88B 578.5M 2025-12
CVS Health USD 60.53B 29M 2026-03
Danaher USD 17.56B 855M 2026-03
Dentsply International USD 2.01B 9M 2026-03
Dexcom USD 1.3B 54.4M 2026-03
Henry Schein USD 2.33B 17M 2026-03
Idexx Laboratories USD 299.85M 74.99M 2026-03
Insulet USD 929.5M 1.3M 2026-03
Integra LifeSciences USD 1.83B 29.45M 2026-03
IQVIA Holdings USD 13.99B 105M 2026-03
Masimo USD 445.7M 72.3M 2026-03
McKesson USD 5.26B 166M 2026-03
Mettler Toledo International USD 2.16B 73.35M 2026-03
Revvity USD 2.63B 836K 2026-03
Solventum Corp USD 4.58B 460M 2026-03
Stryker USD 14.22B 635M 2026-03
Teleflex USD 2.51B 27.18M 2026-03
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Waters USD 5.22B 3.81B 2026-03
Zimmer Biomet Holdings USD 6.3B 636.9M 2026-03
Zoetis USD 9.04B 3M 2026-03